Investor mix
9 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 33% |
| Private equity | 2 | 22% |
| Other / undisclosed | 4 | 44% |
Develops monoclonal antibodies to treat cancer
9 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 33% |
| Private equity | 2 | 22% |
| Other / undisclosed | 4 | 44% |